6796.TW MedImaging Integrated Solution Inc.
- Market cap
- TWD 1.99B
- P/E
- 126.5x
- P/B
- 2.33x
- ROE
- -5.1%
- Dividend yield
- 0.88%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 6796.TW undervalued?
Graham numberThe Graham number of MedImaging Integrated Solution Inc. cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MedImaging Integrated Solution Inc. fundamental analysis
No fundamental analysis for MedImaging Integrated Solution Inc. yet.
MedImaging Integrated Solution Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MedImaging Integrated Solution Inc.
Medimaging Integrated Solution Inc. engages in the design, manufacture and sale of digital medical imaging diagnostic equipments. It also provides digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes, as well as auxiliary tools. It also offers horus scope products, including optical coherence tomography products, control units, scopes, software, and accessories; computing-based AI screening solutions in diabetic …
Full company profileMedImaging Integrated Solution Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
MedImaging Integrated Solution Inc. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 368M | 315M | 402M | 486M | 502M | 537M | 539M | 661M | 618M |
| Gross Profit | 217M | 175M | 219M | 256M | 254M | 308M | 234M | 277M | 230M |
| Operating Income | 68.0M | 5.70M | 64.8M | 86.6M | 59.7M | 91.9M | -2.42M | 17.9M | -57.8M |
| EBITDA | 90.5M | 32.9M | 90.4M | 115M | 119M | 119M | 50.9M | 74.5M | -1.99M |
| Net Income | 58.6M | 4.78M | 54.1M | 66.5M | 70.0M | 74.1M | 5.61M | 7.73M | -43.2M |
| EPS | 1.77 | 0.15 | 1.70 | 2.04 | 1.97 | 1.98 | 0.15 | 0.20 | -1.07 |
| Balance Sheet | |||||||||
| Total Assets | - | 502M | 618M | 716M | 841M | 1.34B | 1.36B | 1.57B | 1.65B |
| Total Liabilities | - | 164M | 228M | 230M | 193M | 548M | 614M | 826M | 802M |
| Shareholders' Equity | - | 338M | 390M | 486M | 648M | 793M | 742M | 745M | 852M |
| Cash & Short-term Investments | - | 143M | 195M | 234M | 335M | 658M | 380M | 547M | 617M |
| Total Debt | - | 78.6M | 136M | 136M | 87.7M | 405M | 443M | 674M | 453M |
| Cash Flow | |||||||||
| Operating Cash Flow | - | -13.3M | 55.8M | 46.0M | 113M | 168M | -50.4M | -16.2M | -66.3M |
| Capital Expenditure | - | 33.6M | 41.5M | 30.8M | 50.7M | 199M | 125M | 37.1M | 29.2M |
| Free Cash Flow | - | -46.9M | 14.3M | 15.1M | 62.1M | -30.9M | -176M | -53.3M | -95.4M |
| Ratios | |||||||||
| ROE | - | 1.4% | 13.9% | 13.7% | 10.8% | 9.3% | 0.8% | 1.0% | -5.1% |
| ROA | - | 1.0% | 8.8% | 9.3% | 8.3% | 5.5% | 0.4% | 0.5% | -2.6% |
| Net Profit Margin | 15.9% | 1.5% | 13.4% | 13.7% | 13.9% | 13.8% | 1.0% | 1.2% | -7.0% |
| Debt to Equity | - | 0.23x | 0.35x | 0.28x | 0.14x | 0.51x | 0.60x | 0.90x | 0.53x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
MedImaging Integrated Solution Inc. dividends
- Dividend yield
- 0.88%
- Forward dividend
- 0.25 TWD
- Payout ratio
- 225.0%
- Ex-dividend date
- Jul 24, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | TWD 17.4M | 0.45 | 225.0% |
| 2024 | TWD 62.3M | 1.62 | 1,109.6% |
| 2023 | TWD 59.8M | 1.60 | 80.8% |
| 2022 | TWD 53.2M | 1.49 | 76.0% |
| 2021 | TWD 36.0M | 1.11 | 54.2% |
| 2020 | TWD 4.49M | 0.14 | 8.3% |
| 2019 | TWD 46.9M | 1.49 | 981.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1100:1000 on Aug 19, 2025.
Who owns MedImaging Integrated Solution Inc.
- Insiders 47.07%
- Institutions 0.04%
- Public & others 52.90%
- Shares outstanding 40.2M
- Free float 22.0M
MedImaging Integrated Solution Inc. company profile
- Company name
- MedImaging Integrated Solution Inc.
- Ticker
- 6796.TW
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- December
- Address
- No. 11, Park Avenue II, Hsinchu City, Taiwan, 300091
- Phone
- 886 3 579 8860
- Website
- miis.com.tw
About MedImaging Integrated Solution Inc.
Medimaging Integrated Solution Inc. engages in the design, manufacture and sale of digital medical imaging diagnostic equipments. It also provides digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes, as well as auxiliary tools. It also offers horus scope products, including optical coherence tomography products, control units, scopes, software, and accessories; computing-based AI screening solutions in diabetic retinopathy, wound care, and medical diagnosis; endoscopy solutions comprising a micro camera module for visualization performance and patient-oriented care; and micro camera modules. The company was founded in 2010 and is headquartered in Hsinchu City, Taiwan.
MedImaging Integrated Solution Inc. management
5- Mr. Chu-Ming ChengCEO, Chairman & President
- Mr. Chih-Lu HsuVice President
- Ms. Hui-Yu KoVice President
- Ching Yi FanDeputy Director of the Finance & Accounting
- Shih-Ting HuangChief Accounting Officer